Nova Realidade Covid-19 após 1 ano

Trends • The domestic pharmaceutical market is expected to accelerate in 2021, due to an increased focus on the health and well-being of the population during the COVID- 19 pandemic and on improving economic conditions. Cheaper generic drugs will continue to be the main driving force, supported by new product launches and government cost-cutting measures. • The domestic pharmaceutical market is expected to accelerate in 2021, due to an increased focus on the health and well-being of the population during the COVID- 19 pandemic and on improving economic conditions. Cheaper generic drugs will continue to be the main driving force, supported by new product launches and government cost-cutting measures. • The growth of chronic diseases and government efforts to ensure adequate vaccines and medical treatment for COVID-19 for the population will increase the demand for patented drugs, however, the profitability of the local industry will remain hampered by three main factors: A. Increased costs of imported inputs due to the devaluation of the Brazilian Real; B. Excessive tax burden; C. Governmental mechanism to control drug prices. KPMG © 2021 KPMG Auditores Independentes, a Brazilian entity and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved. Printed in Brazil. BD210890 Page | 109

View entire presentation